137 studies found for:    Open Studies | "Thrombocytopenia"
Show Display Options
Rank Status Study
21 Recruiting An Investigation of Dexamethasone With Different Doses in the Management of Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Drug: Dexamethasone
22 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platlet count);   Drug: avatrombopag (higer baseline platelet count);   Drug: placebo (higher baseline platelet count)
23 Recruiting Treatment of Thrombocytopenia in Patients With Chronic Liver Disease Undergoing an Elective Procedure
Condition: Thrombocytopenia Associated With Liver Disease
Interventions: Drug: avatrombopag (lower baseline platelet count);   Drug: placebo (lower baseline platlet count);   Drug: avatrombopag (higer baseline platelet count);   Drug: placebo (higher baseline platelet count)
24 Recruiting A Study Evaluating the Safety and Efficacy of Long-term Dosing of Romiplostim in Thrombocytopenic Pediatric Subjects With Immune (Idiopathic) Thrombocytopenia Purpura
Condition: Thrombocytopenia in Pediatric Subjects With Immune (Idiopathic) Thrombocytopenic Purpura (ITP)
Intervention: Biological: Romiplostim
25 Recruiting Thrombocytopenia and Bleeding in Wiskott-Aldrich Syndrome (WAS) Patients
Conditions: Wiskott-Aldrich Syndrome;   Thrombocytopenia;   Bleeding
Interventions: Drug: Promacta (eltrombopag);   Drug: Eltrombopag/promacta
26 Recruiting Eltrombopag in Myelodysplastic Syndrome (MDS) Patients With Thrombocytopenia
Conditions: Myelodysplastic Syndrome (MDS);   Thrombocytopenia
Intervention: Drug: Eltrombopag
27 Recruiting Eltrombopag for Thrombocytopenia in Patients With Relapsed Multiple Myeloma
Conditions: Thrombocytopenia;   Multiple Myeloma
Intervention: Drug: Eltrombopag
28 Unknown  Efficacy of Helicobacter Pylori Eradication, Anti-D and Danazol Combination in Steroid Dependant or Refractory Immune Thrombocytopenia (ITP)
Condition: Thrombocytopenia
Intervention: Other: Steroid refractory ITP
29 Not yet recruiting Oxidant Status and Effect of Antioxidant in Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Antox tablets(Mepaco);   Other: drug therapy for ITP
30 Recruiting Study Evaluating The Effects Of Oprelvekin On Cardiac Repolarization In Subjects With Chemotherapy Induced Thrombocytopenia
Condition: Severe Thrombocytopenia
Intervention: Drug: oprelvekin
31 Recruiting Single Rising Dose Study of MK-8723 in Healthy Participants and Participants With Immune Thrombocytopenia Purpura (MK-8723-001)
Condition: Immune Thrombocytopenia Purpura
Interventions: Drug: MK-8723;   Drug: Matching Placebo
32 Recruiting Using ROMIPLOSTINE for Persistent Thrombocytopenia With Transfusion-dependent Patients Who Received Allogeneic Hematopoietic Stem Cell
Condition: Persistent Thrombocytopenia Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Intervention: Drug: Romiplostim
33 Recruiting The International ITP Registry
Condition: Thrombocytopenia
Intervention:
34 Unknown  Immune Thrombocytopenia (ITP) Immune-Genetic Assessment
Condition: Thrombocytopenia
Intervention:
35 Recruiting Treating Patients With High-Grade Glioma With Intra-Arterial (IA) Carboplatin-based Chemotherapy, With or Without Sodium Thiosulfate
Conditions: Brain and Central Nervous System Tumors;   Thrombocytopenia
Interventions: Drug: Carboplatin;   Drug: Cyclophosphamide;   Drug: Etoposide phosphate;   Drug: Etoposide;   Drug: Sodium thiosulfate
36 Recruiting Alteration of Different Immune Parameters in Immune Thrombocytopenia (ITP) Patients Receiving Eltrombopag Treatment
Condition: Immune Thrombocytopenia
Intervention:
37 Recruiting A Multicentre Investigation of 2 Cycles Rituximab Compared With Standard Regimen in Management of Steroid-Resistant/Relapsed Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Drug: Rituximab
38 Recruiting ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
Condition: Immune Thrombocytopenia
Intervention: Drug: Second Line ITP agents
39 Recruiting Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
40 Recruiting A Multicentre Investigation of Recombinant Human Thrombopoietin (rhTPO) With Different Frequencies in the Management of ITP
Condition: Immune Thrombocytopenia
Intervention: Drug: Recombinant Human Thrombopoietin (rhTPO)

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years